Renaissance of vancomycin: approaches for breaking antibiotic resistance in multidrug-resistant bacteria - PubMed

Affiliations

• PMID: 31545906
• DOI: 10.1139/cjm-2019-0309

Free article

Review

Renaissance of vancomycin: approaches for breaking antibiotic resistance in multidrug-resistant bacteria

Eric Mühlberg et al. Can J Microbiol. 2020 Jan.

Free article

Abstract

The emergence of multidrug-resistant bacteria demands innovations in the development of new antibiotics. For decades, the glycopeptide antibiotic vancomycin has been considered as the "last resort" treatment of severe infections caused by Gram-positive bacteria. Since the discovery of the first vancomycin-resistant enterococci strains in the late 1980s, the number of resistances has been steadily rising, with often life-threatening consequences. As an alternative to the generation of completely new substances, novel approaches focus on structural modifications of established antibiotics such as vancomycin to overcome these resistances. Here, we provide an overview of several promising modifications of vancomycin to restore its efficacy against vancomycin-resistant enterococci.

Keywords: antibiotics; antibiotiques; bactérie multirésistante aux médicaments; enterococci; entérocoques; modification structurale; multidrug-resistant bacteria; structural modification; vancomycin; vancomycine.

Similar articles

• Vancomycin resistance: occurrence, mechanisms and strategies to combat it.

  Boneca IG, Chiosis G. Boneca IG, et al. Expert Opin Ther Targets. 2003 Jun;7(3):311-28. doi: 10.1517/14728222.7.3.311. Expert Opin Ther Targets. 2003. PMID: 12783569 Review.

• Glycopeptide resistance in enterococci.

  Méndez-Alvarez S, Pérez-Hernández X, Claverie-Martín F. Méndez-Alvarez S, et al. Int Microbiol. 2000 Jun;3(2):71-80. Int Microbiol. 2000. PMID: 11001535 Review.

• Battle against Vancomycin-Resistant Bacteria: Recent Developments in Chemical Strategies.

  Dhanda G, Sarkar P, Samaddar S, Haldar J. Dhanda G, et al. J Med Chem. 2019 Apr 11;62(7):3184-3205. doi: 10.1021/acs.jmedchem.8b01093. Epub 2018 Nov 21. J Med Chem. 2019. PMID: 30404451

• Pursuit of next-generation glycopeptides: a journey with vancomycin.

  Acharya Y, Dhanda G, Sarkar P, Haldar J. Acharya Y, et al. Chem Commun (Camb). 2022 Feb 8;58(12):1881-1897. doi: 10.1039/d1cc06635h. Chem Commun (Camb). 2022. PMID: 35043130 Review.

• A comparative review of the lipoglycopeptides: oritavancin, dalbavancin, and telavancin.

  Guskey MT, Tsuji BT. Guskey MT, et al. Pharmacotherapy. 2010 Jan;30(1):80-94. doi: 10.1592/phco.30.1.80. Pharmacotherapy. 2010. PMID: 20030476 Review.

Cited by

• Selective Modification of Streptozotocin at the C3 Position to Improve Its Bioactivity as Antibiotic and Reduce Its Cytotoxicity towards Insulin-Producing β Cells.

  Zhang J, Yakovlieva L, de Haan BJ, de Vos P, Minnaard AJ, Witte MD, Walvoort MTC. Zhang J, et al. Antibiotics (Basel). 2020 Apr 15;9(4):182. doi: 10.3390/antibiotics9040182. Antibiotics (Basel). 2020. PMID: 32326389 Free PMC article.

• Synergy of the Bacteriocin AS-48 and Antibiotics against Uropathogenic Enterococci.

  Montalbán-López M, Cebrián R, Galera R, Mingorance L, Martín-Platero AM, Valdivia E, Martínez-Bueno M, Maqueda M. Montalbán-López M, et al. Antibiotics (Basel). 2020 Sep 2;9(9):567. doi: 10.3390/antibiotics9090567. Antibiotics (Basel). 2020. PMID: 32887311 Free PMC article.

• Multidrug Resistance (MDR) and Collateral Sensitivity in Bacteria, with Special Attention to Genetic and Evolutionary Aspects and to the Perspectives of Antimicrobial Peptides-A Review.

  Fodor A, Abate BA, Deák P, Fodor L, Gyenge E, Klein MG, Koncz Z, Muvevi J, Ötvös L, Székely G, Vozik D, Makrai L. Fodor A, et al. Pathogens. 2020 Jun 29;9(7):522. doi: 10.3390/pathogens9070522. Pathogens. 2020. PMID: 32610480 Free PMC article. Review.

• Investigation of Antimicrobial Resistance Genes in Listeria monocytogenes from 2010 through to 2021.

  Hanes RM, Huang Z. Hanes RM, et al. Int J Environ Res Public Health. 2022 May 1;19(9):5506. doi: 10.3390/ijerph19095506. Int J Environ Res Public Health. 2022. PMID: 35564901 Free PMC article.

• Phosphate Ions Alter the Binding of Daptomycin to Living Bacterial Cell Surfaces.

  Miller LN, Blake MJ, Page EF, Castillo HB, Calhoun TR. Miller LN, et al. ACS Infect Dis. 2021 Nov 12;7(11):3088-3095. doi: 10.1021/acsinfecdis.1c00397. Epub 2021 Oct 3. ACS Infect Dis. 2021. PMID: 34605244 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ingenta plc

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program